查詢結果分析
來源資料
相關文獻
- Brain Metastasis in Patients with Esophageal Squamous Cell Carcinoma: A Single Institute Experience in Southern Taiwan
- Trimodality Treatment for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma
- 晚期食道癌免疫治療之新進展
- p53 Gene Alternation in Squamous Cell Carcinoma of the Esophagus Detected by PCR-Cold SSCP Analysis
- Treatment of Ultra-High Risk Gestational Trophoblastic Disease by an EMA/CE Regimen
- 小型肝癌併腦部轉移
- Hemorrhagic Cerebellar Metastasis from Papillary Thyroid Carcinoma
- Clinical Application of Ultrasonic Mini-Probes in Esophageal Cancer: The Experience of Ntuh
- 軟侸的類基底鱗狀細胞癌--病例報告
- 利用鐳射流體細胞儀回溯研究口腔鱗狀細胞癌之去氧核糖核酸套數
頁籤選單縮合
題 名 | Brain Metastasis in Patients with Esophageal Squamous Cell Carcinoma: A Single Institute Experience in Southern Taiwan=食道鱗狀細胞癌病人合併腦轉移:單一醫學中心之經驗 |
---|---|
作 者 | 陳彥豪; 王友明; 呂宏益; 李道真; 黃承華; 謝敏暲; 方富民; 饒坤銘; 陳彥仰; 李劭軒; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 29:4 2013.12[民102.12] |
頁 次 | 頁182-189 |
分類號 | 416.241 |
關鍵詞 | 食道癌; 鱗狀細胞癌; 腦轉移; Esophageal cancer; Squamous cell carcinoma; Brain metastasis; |
語 文 | 英文(English) |
中文摘要 | 目的:食道鱗狀細胞癌的病人預後極差。常見的轉移部位包括肺、肝、骨、肋膜及腎上 腺,但腦轉移的案例相對較少。由於過去關於食道鱗狀細胞癌病人合併腦轉移的文獻報 告並不多,藉此研究,我們想要探討食道鱗狀細胞癌病人合併腦轉移的發生率及其預後。 方法:1011 位食道鱗狀細胞癌病患於 1996 年至 2011 年在本院診斷,其中合併腦轉移的 有 14 位。腦轉移的診斷依據組織學報告或影像學檢查,包括電腦斷層和核磁共振。 結果:腦轉移的發生率為 1.4%。從診斷食道癌到發生腦轉移的平均追蹤時間為 6.6 個月。 14 位腦轉移的病人中,有 10 位(71%)同時合併其他器官轉移。在腦轉移部分,6 個病人(43%) 為單一腦病灶、2 個病人(14%)為兩個腦病灶、其餘 6 位(43%)為多發性腦病灶。在治療部 分,5 個病人(36%)接受全腦照射、6 個病人(43%)接受手術切除,其中 5 人術後亦接受全 腦照射、其餘 3 人(21%)只接受支持性治療。單變項分析發現單一腦轉移病灶(P=0.005)、 接受手術切除及全腦照射(P=0.002)及沒有其他器官轉移(P=0.03)的病人有較好的預後。 結論:單一腦轉移病灶及沒有其他器官轉移的病人有明顯之存活率的改善。針對這群病 人,應該考慮積極治療。 |
英文摘要 | Background: Patients with esophageal squamous cell carcinoma typically have poor outcomes. The lungs, liver, bone, pleura and adrenal gland are the most common sites of visceral metastasis, though metastasis to the brain is exceedingly rare. To date, there have been few reports concerning the clinical outcome of brain metastasis in esophageal squamous cell carcinoma. Therefore, we performed a retrospective review of esophageal squamous cell carcinoma patients with brain metastasis to assess the incidence of brain metastasis and their prognosis. Methods: Between January 1996 and December 2011, 1011 patients with esophageal squamous cell carcinoma were retrospectively reviewed, and 14 patients with brain metastases were identified. The review and diagnoses of brain metastasis were established using brain computer tomography (CT) scan, or magnetic resonance imaging (MRI). Results: The incidence of brain metastasis in our series was 1.4%, and the median survival duration from the diagnosis of brain metastasis in these 14 patients with esophageal squamous cell carcinoma was 1.9 months. The median follow-up period from the diagnosis of esophageal cancer to the diagnosis of brain metastasis was 6.6 months. Systemic metastasis upon diagnosis of brain metastasis was found in 10 patients (71%), a single brain metastasis was found in 6 patients (43%), two brain lesions were found in 2 patients (14%), and multiple brain metastases were found in 6 patients (43%). Primary treatment consisted of whole brain irradiation therapy (WBRT) alone in 5 patients (36%), surgical resection in 6 patients (43%), 5 of whom (36%) subsequently were treated with WBRT, and best supportive care in three patients (21%). Univariate analysis showed that patients with single brain metastasis (P = 0.004), treatment with surgical resection plus whole brain radiation therapy (P = 0.002), and absence of systemic metastasis (P = 0.03) were significantly associated with better clinical outcome. Conclusions: The incidence of brain metastasis in esophageal squamous cell carcinoma is 1.4%, and the prognosis is poor. Patients without systemic metastases or with single brain metastasis have significantly superior survival rates, suggesting that aggressive therapy should be considered in these groups of patients. |
本系統中英文摘要資訊取自各篇刊載內容。